The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned ...

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...

Mounjaro, which treats type 2 diabetes, has recently been approved for weight ... Any member of the public or health ...

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versi ...

(MENAFN- ForPressRelease) 11th November, 2024– As global mobility surges, managing chronic conditions like diabetes during travel has become a significant concern. Diabetes remains one of the ...

Novo Nordisk and Eli Lilly are both raking in billions from their blockbuster weight loss drugs that are also approved to ...

If you double up on your dose, it is possible to overdose on Ozempic. Here's what to know—including side effects and what to ...